ArticleInternational journal of women's health2026
Global, Regional, and National Burden and Trends of Hypertensive Heart Disease Among Women of Childbearing Age from 1992 to 2021.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertensive heart disease (HHD) is an important contributor to cardiovascular morbidity among women of childbearing age (WCBA), yet long-term global trends in this population remain insufficiently characterized. We aimed to describe the prevalence, mortality, and disability-adjusted life years (DALYs) of HHD among WCBA at global, regional, and national levels and to assess temporal patterns from 1992 to 2021. Methods: Data were obtained from the Global Burden of Disease (GBD) 2021 study. We estimated numbers and age-standardized rates of prevalence, mortality, and DALYs for women aged 15-49 years. An age-period-cohort (APC) model was applied to disentangle age, period, and cohort effects on mortality trends. Results: From 1992 to 2021, the global burden of HHD among WCBA exhibited a divergent trend: while the prevalence rate increased steadily from 20.09% to 27.94%, mortality and DALY rates generally declined. In 2021, significant regional disparities existed, with the middle-SDI region recording the highest prevalence, whereas the high-middle SDI region achieved the lowest mortality and DALY rates. APC analyses for mortality further clarified these shifts: period-effect risks declined across most SDI groups but notably increased in high-SDI countries. Similarly, while cohort-effect risks significantly reduced in most regions, high-SDI countries exhibited a distinct pattern of an initial risk rise followed by a subsequent decline. Conclusion: Global HHD trends among WCBA are characterized by rising prevalence alongside declining mortality and DALY rates. Marked disparities persisted across SDI regions, with the highest prevalence in middle-SDI settings and more variable mortality patterns in high-SDI settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.